Cite
Contribution of traditional Japanese Kampo medicines, kakkonto with shosaikotokakikyosekko, in treating patients with mild-to-moderate coronavirus disease 2019: Further analysis of a multicenter, randomized controlled trial.
MLA
Takayama, Shin, et al. “Contribution of Traditional Japanese Kampo Medicines, Kakkonto with Shosaikotokakikyosekko, in Treating Patients with Mild-to-Moderate Coronavirus Disease 2019: Further Analysis of a Multicenter, Randomized Controlled Trial.” Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy, vol. 29, no. 11, Nov. 2023, pp. 1054–60. EBSCOhost, https://doi.org/10.1016/j.jiac.2023.07.013.
APA
Takayama, S., Namiki, T., Arita, R., Ono, R., Kikuchi, A., Ohsawa, M., Saito, N., Suzuki, S., Nakae, H., Kobayashi, S., Yoshino, T., Ishigami, T., Tanaka, K., Takagi, A., Yamaguchi, T., Ishii, T., Hisanaga, A., Mitani, K., & Ito, T. (2023). Contribution of traditional Japanese Kampo medicines, kakkonto with shosaikotokakikyosekko, in treating patients with mild-to-moderate coronavirus disease 2019: Further analysis of a multicenter, randomized controlled trial. Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy, 29(11), 1054–1060. https://doi.org/10.1016/j.jiac.2023.07.013
Chicago
Takayama, Shin, Takao Namiki, Ryutaro Arita, Rie Ono, Akiko Kikuchi, Minoru Ohsawa, Natsumi Saito, et al. 2023. “Contribution of Traditional Japanese Kampo Medicines, Kakkonto with Shosaikotokakikyosekko, in Treating Patients with Mild-to-Moderate Coronavirus Disease 2019: Further Analysis of a Multicenter, Randomized Controlled Trial.” Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy 29 (11): 1054–60. doi:10.1016/j.jiac.2023.07.013.